Your browser doesn't support javascript.
loading
The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis.
Fukasawa, Takemichi; Yamashita, Takashi; Enomoto, Atsushi; Norimatsu, Yuta; Toyama, Satoshi; Yoshizaki-Ogawa, Asako; Tateishi, Shoko; Kanda, Hiroko; Miyagawa, Kiyoshi; Sato, Shinichi; Yoshizaki, Ayumi.
Afiliación
  • Fukasawa T; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Yamashita T; Department of Clinical Cannabinoid Research, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Enomoto A; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Norimatsu Y; Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Toyama S; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Yoshizaki-Ogawa A; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Tateishi S; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Kanda H; Immune-Mediated Diseases Therapy Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Miyagawa K; Immune-Mediated Diseases Therapy Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Sato S; Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Yoshizaki A; Department of Dermatology, Psoriasis Center, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Front Immunol ; 14: 1286251, 2023.
Article en En | MEDLINE | ID: mdl-37928519

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica Límite: Aged / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica Límite: Aged / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza